Market Cap 1.91B
Revenue (ttm) 211.08M
Net Income (ttm) -51.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.19%
Debt to Equity Ratio 10.51
Volume 301,300
Avg Vol 515,156
Day's Range N/A - N/A
Shares Out 29.39M
Stochastic %K 57%
Beta 1.08
Analysts Strong Sell
Price Target $90.88

Company Profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment...

Industry: Medical Devices
Sector: Healthcare
Phone: 800 924 5072
Address:
11401 century oaks terrace, suite 400, Austin, United States
TriGuy8542
TriGuy8542 Apr. 21 at 5:19 PM
$ESTA bought a bunch more this morning. This companies product will own the big ticket plastic surgeries .
0 · Reply
Lambster2
Lambster2 Apr. 21 at 10:15 AM
$ESTA Cowen update. Establishment Labs (NASDAQ: ESTA) Buy (1) ESG Score: 47/100 Price Target: $95.00 The Innovation Gap Is Widening: KOLs Are Believers in ESTA's Emerging Dominance THE TD COWEN INSIGHT Our visit to Establishment Labs’ surgeon training weekend reinforced our highly constructive view on the portfolio, with surgeons giving notably positive feedback on Motiva, Ergonomix 1/2, Preservé, and MIA. We came away believing Establishment increasingly looks like the only active innovator in breast implants, positioning the company to take disproportionate share. Reiterate Buy, $95 PT.
1 · Reply
TriGuy8542
TriGuy8542 Apr. 17 at 2:01 PM
$ESTA I added more this morning. Things one you have to wait until earnings for then it will smash upwards and continue on. They get bought out as the most innovative plastic surgery product in a long time. It’s just a matter of when.
0 · Reply
TriGuy8542
TriGuy8542 Apr. 16 at 4:26 PM
$ESTA healthcare just hasn’t been picking up the bid. It’s that simple sometimes. Have to wait for the rotation
0 · Reply
Thestockguy77
Thestockguy77 Apr. 15 at 9:15 PM
$ESTA well the market def does not move this, good or bad.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 14 at 6:55 PM
$ESTA W earnings coming next month and the technicals getting v bullish we will go back to ATHs
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 14 at 1:33 PM
$ESTA About to recapture the 50DMA
0 · Reply
TriGuy8542
TriGuy8542 Apr. 8 at 2:22 PM
$ESTA in for 257 shares for now. Will continue to add when there’s more certainty to the market.
0 · Reply
Lambster2
Lambster2 Apr. 8 at 1:56 PM
$ESTA Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market https://share.google/mQ3r2dlW4SscS511G
0 · Reply
Lambster2
Lambster2 Apr. 8 at 12:05 PM
$ESTA Mizuho update from 3/24 3/24/26 Mizuho says ESTA shares are down 28% since February 28, the first day of the U.S.-Iran conflict, which is “unwarranted and overdone.” ESTA has pulled back on concerns that rising oil prices will pressure the company’s margins and consumer demand, the analyst tells investors in a research note. Mizuho adds that the stock has been weak more recently on “unsubstantiated evidence” of a short report and insider selling from former CEO Jaun Jose Chacon. The firm believes the macro concerns are “well overdone” considering ESTA purchases silicone under forward contracts while demand at the consumer level, particularly for Preserve, “remains robust.” Further, no short report was published, and insider selling is part of a planned previously disclosed 10b5-1 plan, contends Mizuho. As such, it views the stock’s current weakness as an “attractive entry point into a best-in-class growth story.” Mizuho has an Outperform rating on ES5A with a $100 price target
0 · Reply
Latest News on ESTA
Establishment Labs Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 8:00 AM EST - 6 months ago

Establishment Labs Reports Third Quarter 2025 Financial Results


Establishment Labs Hosting Investor Day on June 12

Jun 11, 2025, 7:07 PM EDT - 11 months ago

Establishment Labs Hosting Investor Day on June 12


Establishment Labs Launches Preservé™

Feb 18, 2025, 8:00 AM EST - 1 year ago

Establishment Labs Launches Preservé™


Establishment Labs Announces CEO Transition

Jan 13, 2025, 8:00 AM EST - 1 year ago

Establishment Labs Announces CEO Transition


TriGuy8542
TriGuy8542 Apr. 21 at 5:19 PM
$ESTA bought a bunch more this morning. This companies product will own the big ticket plastic surgeries .
0 · Reply
Lambster2
Lambster2 Apr. 21 at 10:15 AM
$ESTA Cowen update. Establishment Labs (NASDAQ: ESTA) Buy (1) ESG Score: 47/100 Price Target: $95.00 The Innovation Gap Is Widening: KOLs Are Believers in ESTA's Emerging Dominance THE TD COWEN INSIGHT Our visit to Establishment Labs’ surgeon training weekend reinforced our highly constructive view on the portfolio, with surgeons giving notably positive feedback on Motiva, Ergonomix 1/2, Preservé, and MIA. We came away believing Establishment increasingly looks like the only active innovator in breast implants, positioning the company to take disproportionate share. Reiterate Buy, $95 PT.
1 · Reply
TriGuy8542
TriGuy8542 Apr. 17 at 2:01 PM
$ESTA I added more this morning. Things one you have to wait until earnings for then it will smash upwards and continue on. They get bought out as the most innovative plastic surgery product in a long time. It’s just a matter of when.
0 · Reply
TriGuy8542
TriGuy8542 Apr. 16 at 4:26 PM
$ESTA healthcare just hasn’t been picking up the bid. It’s that simple sometimes. Have to wait for the rotation
0 · Reply
Thestockguy77
Thestockguy77 Apr. 15 at 9:15 PM
$ESTA well the market def does not move this, good or bad.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 14 at 6:55 PM
$ESTA W earnings coming next month and the technicals getting v bullish we will go back to ATHs
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 14 at 1:33 PM
$ESTA About to recapture the 50DMA
0 · Reply
TriGuy8542
TriGuy8542 Apr. 8 at 2:22 PM
$ESTA in for 257 shares for now. Will continue to add when there’s more certainty to the market.
0 · Reply
Lambster2
Lambster2 Apr. 8 at 1:56 PM
$ESTA Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market https://share.google/mQ3r2dlW4SscS511G
0 · Reply
Lambster2
Lambster2 Apr. 8 at 12:05 PM
$ESTA Mizuho update from 3/24 3/24/26 Mizuho says ESTA shares are down 28% since February 28, the first day of the U.S.-Iran conflict, which is “unwarranted and overdone.” ESTA has pulled back on concerns that rising oil prices will pressure the company’s margins and consumer demand, the analyst tells investors in a research note. Mizuho adds that the stock has been weak more recently on “unsubstantiated evidence” of a short report and insider selling from former CEO Jaun Jose Chacon. The firm believes the macro concerns are “well overdone” considering ESTA purchases silicone under forward contracts while demand at the consumer level, particularly for Preserve, “remains robust.” Further, no short report was published, and insider selling is part of a planned previously disclosed 10b5-1 plan, contends Mizuho. As such, it views the stock’s current weakness as an “attractive entry point into a best-in-class growth story.” Mizuho has an Outperform rating on ES5A with a $100 price target
0 · Reply
Lambster2
Lambster2 Apr. 8 at 12:02 PM
$ESTA More info on Citi PT cut 4/7/26 - Citi analyst Joanne Wuensch lowered the firm’s price target on Establishment Labs (ESTA) to $65 from $74 and keeps a Neutral rating on the shares. The firm adjusted targets in the medical technology group as part of a Q1 preview. The “walls of worry are high” into the earnings reports with the sector undergoing significant multiple compression, the analyst tells investors in a research note. Citi removed iRhythm and Medtronic as top picks. The firm’s top picks are now Edwards Lifesciences and Intuitive Surgical
0 · Reply
Lambster2
Lambster2 Apr. 8 at 11:30 AM
$ESTA Citi cuts PT from 74 to 65. Hmmm
1 · Reply
Fiona22_D
Fiona22_D Apr. 2 at 4:37 PM
$ESTA medtech style mover where low attention can become quick momentum if the breakout level starts getting accepted
0 · Reply
Thestockguy77
Thestockguy77 Apr. 1 at 4:06 PM
$ESTA snapped the last I can buy without using margin… a patient waiting game now.
0 · Reply
Lambster2
Lambster2 Apr. 1 at 1:39 PM
$ESTA No concerns holding this one. Still my second largest holding behind tmdx
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 7:29 PM
$ESTA Looks like it bounces right off that uptrend line ..bullish
0 · Reply
StardustTrader
StardustTrader Mar. 31 at 3:08 PM
$ESTA assuming no macro headwinds, perfect spot to add. Both weekly and monthly 50s are right at 50/share. This should bounce soon.
0 · Reply
TriGuy8542
TriGuy8542 Mar. 31 at 2:55 PM
$ESTA I know this is trending with IHI, but I don’t how it’s going to not be purchased by some big healthcare entity as it continues to disrupt the market.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Mar. 29 at 2:31 PM
$ESTA and $TMDX these two should be rockin, but they are flopping. @Doozio
1 · Reply
OptionRunners
OptionRunners Mar. 27 at 8:22 PM
2 large trades minutes before the close $ESTA roll/adjustment to the May $45 puts and they're not taking any risk off And a $RGEN May $110 call buyer Have a good weekend!
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 27 at 8:19 PM
$ESTA This isn’t company specific they are a consumer discretionary company in an economy that may go into a recession due to higher oil prices which we know has 0 to do with this company. It’s all perception Their revenue growth is stellar w 20% US market share and rising Just have to ride the waves and if somebody was looking to buy them last month well they should be looking now …
0 · Reply
Leeststorm
Leeststorm Mar. 27 at 4:01 PM
$ESTA rubbish
0 · Reply